/Companies

LifeCyte Innovations

Greensboro, US · Founded 2024

Find your way into LifeCyte Innovations

Sign up to see every warm intro you have to LifeCyte Innovations

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the LifeCyte Innovations team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

LifeCyte develops oral combination therapies that target chronic inflammation at the cellular level to slow the progression of age-related degenerative diseases such as macular degeneration, mild cognitive impairment, Alzheimer's, and traumatic brain injury. Its lead prototype, RestoViz, is aimed at age-related macular degeneration in older adults.

Founders & leadership

LifeCyte Innovations was founded in 2024 by Ken Brown.

KB
Ken BrownCEO & Co-Founder
MM
Michael MoorheadExecutive
HR
Howard RosingChief Medical Officer
KA
Kenn AdachChief Marketing & Sales Officer
MP
Max PfahlerDirector of Clinical Research

Reported raises · per SEC filings

Form D private placements

$1M disclosed across 1 round · 2026

▶$1MraisedAug 2026 · 3 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Kenneth BrownExecutive Officer, Director
  • Michael MoorheadExecutive Officer, Director
Offering amount
$5M
Amount sold
$1M
First sale
Aug 2026
Incorporated
Corporation, Iowa, 2024
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does LifeCyte Innovations do?
LifeCyte develops oral combination therapies that target chronic inflammation at the cellular level to slow the progression of age-related degenerative diseases such as macular degeneration, mild cognitive impairment, Alzheimer's, and traumatic brain injury. Its lead prototype, RestoViz, is aimed at age-related macular degeneration in older adults.
Who founded LifeCyte Innovations?
LifeCyte Innovations was founded by Ken Brown in 2024.
How much funding has LifeCyte Innovations raised?
LifeCyte Innovations has disclosed $1M raised across 1 round.
Where is LifeCyte Innovations headquartered?
LifeCyte Innovations is headquartered in Greensboro, US.